Bernhard Becker

Technical University of Munich

Papers

2

Total Citations

31

H-Index

2

About

Bernhard Becker is a pioneering figure in the development of sensor-based technologies for personalized cancer therapy. His research centers on label-free, real-time screening systems that enable high-throughput analysis of cellular responses to chemotherapeutic agents. Becker’s most influential work, "Sensor-based cell and tissue screening for personalized cancer chemotherapy" (2012, 24 citations), introduced a paradigm for tailoring treatment by monitoring living tumor tissue ex vivo, bridging the gap between laboratory assays and clinical decision-making. He further advanced the field with the "Automated multi-parametric label free 24 channel real-time screening system" (2008, 7 citations), a platform that allows simultaneous, non-invasive tracking of multiple cellular parameters. These contributions have laid the groundwork for more precise, patient-specific cancer treatments, reducing reliance on broad-spectrum chemotherapy. Though his citation counts reflect a niche but critical area, Becker’s work is foundational for researchers developing microfluidic and biosensor-based diagnostics. His achievements underscore a commitment to translating engineering innovations into tangible clinical tools, making him a key figure in the intersection of biomedical engineering and oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
31
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Sensor-based cell and tissue screening for personalized cancer chemotherapy
24 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Technical University of Munich

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago